Fig. 1.
Survival data in unmutated or mutated B-CLL cases and cases using mutated VH3-21 genes.
Median survival for the unmutated cases (n = 63) was 71 months, mutated cases (n = 37, excluding mutated VH3-21 cases) 147 months, and mutated VH3-21 cases (n = 12) 63 months. The difference in median survival was statistically significant between unmutated versus mutated cases, P < .001, and mutated versus mutated VH3-21 cases, P = .018.
